- Immune Monitoring of Cancer Vaccines
-
Wang E, Panelli MC, Monsurro V, Ping J, Zavaglia K, Marincola
- KMID: 1726151
- Yonsei Med J.
- 2004 Jun;45(Suppl):S71A2-S72A2.
- doi: 10.3349/ymj.2004.45.Suppl.71A2
The recent progress in tumor immunology exemplifies the successful application of modern biotechnology for the understanding of the complex natural or therapy-induced phenomenon of immune-mediated rejection of cancer. Tumor antigens... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality assessment of cellular therapies: the emerging role of molecular assays
-
Stroncek D, Jin P, Ren J, Feng J, Castiello , Civini S, Wang E, Marincola , Sabatino M
- KMID: 2252078
- Korean J Hematol.
- 2010 Mar;45(1):14-22.
- doi: 10.5045/kjh.2010.45.1.14
Cellular therapies are becoming increasingly important in treating cancer, hematologic malignancies, autoimmune disorders, and damaged tissue. These therapies are becoming more effective and are being used more frequently, but they... -
- CITED
-
- Close
- SHARE
-
- Close
- Mechanism of Immune Response During Immunotherapy
-
Panelli MC, Nagorsen D, Wang E, Monsurro V, Jin P, Katia Z, Smith K, Ngalame Y, Marincola
- KMID: 1726139
- Yonsei Med J.
- 2004 Jun;45(Suppl):S15-S17.
- doi: 10.3349/ymj.2004.45.Suppl.15
Tumor immunology embraces an extensive array of biological phenomena that include interactions between neoplastic cells and the innate and adaptive immune response. Among immune cells, T cells have taken the... -
- CITED
-
- Close
- SHARE
-
- Close
